BVF Partners L P/il, 10% Owner at LIGAND PHARMACEUTICALS INC (LGND), bought 511,040 shares at $11.01 ($5.4M) on 2011-11-18, disclosed to the SEC on 2011-11-22.
Open-market purchase of $5.4M LGND by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.01 | 9,951 | $110K | 2.0% |
| 2 | $11.01 | 16,292 | $179K | 3.3% |
| 3 | $11.01 | 46,426 | $511K | 9.4% |
| 4 | $10.59 | 60,100 | $636K | 11.7% |
| 5 | $10.59 | 98,171 | $1.0M | 19.1% |
| 6 | $10.59 | 280,100 |
| $3.0M |
| 54.5% |
| Total | $10.65 avg | 511,040 | $5.4M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |